Ventuno Biotech

Cartography is an oncology company that develops cancer immunotherapies that target novel and highly specific tumor antigens.

Repair Biotechnologies is a biotechnology company developing therapies based on the cholesterol-degrading platform.

Skeletalis develops precision medicines targeting bone loss to treat osteoporosis and prevent fractures safely.

T-Therapeutics is a next-generation T cell receptor (TCR) company spun off from the University of Cambridge.

Azalea Therapeutics is a biotechnology company with a primary focus on developing cancer immunotherapies.

Braveheart Bio is a clinical-stage biotechnology company focused on developing precision therapies in the cardiovascular disease space.

Adaptam Therapeutics is at the forefront of next-generation cancer immunotherapies

Zag Bio is a biotechnology company that designs thymus-targeting bifunctional antibody medicines to treat and prevent autoimmune diseases.

Excellergy develops portfolio of trifunctional effector cell response inhibitors (ECRIs) to combat severe allergic diseases.

Curadel Surgical Innovations oversees the complete process of Curadel's FLARE contrast agents for image-guided surgery.

Treating the seeds of cancer

Nuclide Therapeutics provides radiopharmaceutical medicines that combine nuclear medicine and biotechnology.